Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+193.2%/yr
Quarterly compound
Percentile
P97
Near historical high
vs 3Y Ago
25.2x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 40.00% |
| Q3 2025 | 24.24% |
| Q2 2025 | 8.33% |
| Q1 2025 | -38.46% |
| Q4 2024 | 7.14% |
| Q3 2024 | 17.65% |
| Q2 2024 | 19.05% |
| Q1 2024 | 6.67% |
| Q4 2023 | 2.17% |
| Q3 2023 | 2.13% |
| Q2 2023 | 6.00% |
| Q1 2023 | 19.35% |
| Q4 2022 | 1.59% |
| Q3 2022 | 0.00% |
| Q2 2022 | -8.62% |
| Q1 2022 | 7.94% |
| Q4 2021 | -14.55% |
| Q3 2021 | -3.77% |
| Q2 2021 | -3.92% |
| Q1 2021 | -8.51% |
| Q4 2020 | -17.50% |
| Q3 2020 | 14.89% |
| Q2 2020 | 14.55% |
| Q1 2020 | -10.00% |
| Q4 2019 | -25.00% |
| Q3 2019 | -5.26% |
| Q2 2019 | -26.67% |
| Q1 2019 | -11.11% |
| Q4 2018 | 25.00% |
| Q3 2018 | -5.88% |
| Q2 2018 | -9.68% |
| Q1 2018 | 13.89% |
| Q4 2017 | -2.86% |
| Q3 2017 | 5.41% |
| Q2 2017 | -12.12% |
| Q1 2017 | -32.00% |
| Q4 2016 | 78.26% |
| Q3 2016 | -400.00% |
| Q2 2016 | -64.29% |
| Q1 2016 | 30.00% |